Patient overlap and the validity of SGLT2 inhibitor benefits after TAVI: a critique of recent meta-analytical findings

European Journal of Clinical Pharmacology 2026

View at publisher

Authors: Ahmed Adel Mohamed

DOI: 10.1007/s00228-026-04131-6

Cited by: 1

References: 3

Fields of Study & Subjects

Diabetes Treatment and Management Heart Failure Treatment and Management Pancreatic function and diabetes

References 3